Literature DB >> 7810719

Regulation of ANP secretion by endothelin-1 in cultured atrial myocytes: desensitization and receptor subtype.

M F Leite1, E Page, S K Ambler.   

Abstract

We examined endothelin-1 (ET-1) binding and ET-1-regulated atrial natriuretic peptide (ANP) secretion in primary cultures of adult rat atrial myocytes. ET-1 binding was analyzed as a reversible bimolecular reaction, with bimolecular association rate constant = 1.9 x 10(9) M-1.h-1, dissociation rate constant = 0.028 h-1, and a dissociation constant, calculated from these values = 0.015 nM. ET-1 increased ANP secretion with a one-half effective concentration (EC50) of 0.62 nM, which correlated with EC50 receptor occupancy under equivalent experimental conditions (0.75 nM). The secretory response rapidly desensitized (half-time = 10 min at 10 nM ET-1). The time courses for ET-1 binding, ET-1-stimulated secretion, and desensitization were all comparable. Recovery from desensitization was slow and paralleled the recovery of 125I-labeled ET-1 binding. The ETA receptor subtype-selective antagonist, BQ-123, inhibited 125I-ET-1 binding and ET-1-activated ANP secretion with high affinity, whereas the ETB-selective agonists, endothelin-3 and sarafotoxin S6c, inhibited binding with low affinity and did not effectively stimulate ANP secretion. We conclude that 1) ET-1 can stimulate ANP secretion by direct action on the atrial myocytes; 2) primary cultures of adult rat atrial myocytes express only the ETA receptor subtype; 3) the ANP secretory response to ET-1 desensitizes rapidly but recovers slowly; and 4) occupation of the ETA receptors by ET-1 initiates the unidirectional sequence of receptor activation, signal transduction, ANP secretion, and finally, desensitization.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7810719     DOI: 10.1152/ajpheart.1994.267.6.H2193

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

Review 1.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

2.  A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.

Authors:  J D Molkentin; J R Lu; C L Antos; B Markham; J Richardson; J Robbins; S R Grant; E N Olson
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

3.  CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.

Authors:  R Passier; H Zeng; N Frey; F J Naya; R L Nicol; T A McKinsey; P Overbeek; J A Richardson; S R Grant; E N Olson
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 4.  Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease.

Authors:  Markus P Schneider; Erika I Boesen; David M Pollock
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

Review 5.  Calcineurin regulation of cytoskeleton organization: a new paradigm to analyse the effects of calcineurin inhibitors on the kidney.

Authors:  Virginie Descazeaud; Elodie Mestre; Pierre Marquet; Marie Essig
Journal:  J Cell Mol Med       Date:  2012-02       Impact factor: 5.310

6.  Angiotensin Converting Enzyme Regulates Cell Proliferation and Migration.

Authors:  Erika Costa de Alvarenga; Matheus de Castro Fonseca; Clarissa Coelho Carvalho; Rodrigo Machado Florentino; Andressa França; Eveline Matias; Paola Bianchi Guimarães; Carolina Batista; Valder Freire; Adriana Karaoglanovic Carmona; João Bosco Pesquero; Ana Maria de Paula; Giselle Foureaux; Maria de Fatima Leite
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.